Home Articles posted by PR News Desk (Page 138)
NEWS DESK

Creative Kids Workshops Return to Modesh World 2025 in Partnership with Dubai Government Entities

Get ready to learn, explore, and imagine! Dubai’s favourite characters Modesh and Dana are calling all curious kids and creative minds to join them at Modesh World 2025 for hands-on educational experiences with 24 on-stage workshops, developed in collaboration with various Dubai Government entities. Running daily until 28 August at Dubai World Trade Centre Halls […]
NEWS DESK

Ascott Expands Resort PortfoliO IN THE MIDDLE EAST AND ASIA

The Ascott Limited (Ascott), the wholly owned lodging business unit of CapitaLand Investment (CLI), is scaling its global resort footprint through asset-light expansion. Riding on growing demand for experiential stays, Ascott now has around 50 properties in resort destinations in operation and under development worldwide, supported by 11 new signings in the past 10 months
NEWS DESK

OPPO solidifies global patent leadership, ranked among the world’s top ten Chinese patent filers in Europe and, USA

OPPO, a leading global smart device company, has confirmed its top ten world ranking among patent filers for Chinese companies, announcing that it has filed more than 115,000 patent applications worldwide, with 63,000 granted and approved.   As of July 2025, the global consumer tech powerhouse has filed patents in more than 40 countries and regions,
NEWS DESK

ROLLS-ROYCE MOTOR CARS PRESENTS BESPOKE BLACK BADGE CULLINAN SERIES II ‘DESERT SUNSET’, COMMISSIONED THROUGH PRIVATE OFFICE DUBAI

Rolls-Royce presents its latest Bespoke commission from the Middle East – a captivating Black Badge Cullinan Series II inspired by the unique colours of the sunset over the client’s home city of Doha in Qatar. The motor car’s Bespoke two-tone exterior paint finish features Bronze as the main body colour. This takes its cues from […]
NEWS DESK

Meraki Developers unveils ‘The Haven’ – a landmark residential handover in Majan, Dubailand

Meraki Developers has announced the successful on-schedule handover of The Haven, a landmark residential community located in Majan, Dubailand. This delivery underscores the developer’s commitment to providing a high-quality living experience to residents, who will call The Haven their home. The units are beautifully designed, maximising living spaces with elegant, warm
NEWS DESK

Azizi Developments Renews Bahra Electric Partnership For Busbar And Earthing Lightning Protection Solutions

Azizi Developments, a leading private developer in the UAE, has announced its partnership extension with Bahra Electric, a renowned KSA-based electrical solutions provider. Under this collaboration, Bahra Electric is providing advanced busbar and earthing lightning protection systems across Azizi’s projects in Dubai South, Dubai Healthcare City, Dubai Sports City, and Al
NEWS DESK

Punt Roma Unveils Autumn/Winter 2025 Collection Alongside Launch of New Websites for UAE & KSA

Punt Roma unveils its Autumn/Winter 2025 collection, a celebration of refined femininity and contemporary versatility designed for the modern woman. This season, the brand fuses architectural minimalism with soft, tactile warmth, creating looks that transition effortlessly from day to night and from city streets to weekend escapes. The campaign captures the season’s
NEWS DESK

Mayo Clinic researchers validate blood test to diagnose Alzheimer’s disease in outpatient memory clinics

Alzheimer’s disease, marked by memory loss, trouble concentrating and thinking, and changes in personality and behavior, devastates patients, their families and loved ones. With new treatments available for people with early signs of Alzheimer’s disease, there is a growing need for accessible and cost-effective tests to diagnose the disease sooner. In a new
NEWS DESK

Lilly’s Mounjaro (tirzepatide), a GIP/GLP-1 dual agonist, demonstrated cardiovascular protection in landmark head-to-head trial, reinforcing its benefit in patients with type 2 diabetes and heart disease

Eli Lilly and Company (NYSE: LLY) today announceli ed topline results from SURPASS-CVOT, a first-of-its-kind head-to-head Phase 3 cardiovascular outcomes trial comparing two incretin therapies in adults with type 2 diabetes and established atherosclerotic cardiovascular disease. Mounjaro (tirzepatide), a GIP/GLP-1 dual receptor agonist, was compared to Trulicity